Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

RPG LIFE SCIENCES 2020-21 Annual Report Analysis
Wed, 31 Mar

RPG LIFE SCIENCES has announced its results for the year ended March 2021. Let us have a look at the detailed performance review of the company during FY20-21.

RPG LIFE SCIENCES Income Statement Analysis

  • Operating income during the year rose 3.6% on a year-on-year (YoY) basis.
  • The company's operating profit increased by 29.7% YoY during the fiscal. Operating profit margins witnessed a fall and down at 18.2% in FY21 as against 14.5% in FY20.
  • Depreciation charges increased by 0.7% and finance costs decreased by 35.1% YoY, respectively.
  • Other income grew by 8.1% YoY.
  • Net profit for the year grew by 37.9% YoY.
  • Net profit margins during the year grew from 7.7% in FY20 to 10.3% in FY21.

RPG LIFE SCIENCES Income Statement 2020-21

No. of Mths Year Ending 12 Mar-20* 12 Mar-21* % Change
Net Sales Rs m 3,756 3,891 3.6%
Other income Rs m 10 11 8.1%
Total Revenues Rs m 3,766 3,902 3.6%
Gross profit Rs m 546 708 29.7%
Depreciation Rs m 164 165 0.7%
Interest Rs m 28 18 -35.1%
Profit before tax Rs m 365 536 47.0%
Tax Rs m 74 136 82.5%
Profit after tax Rs m 290 400 37.9%
Gross profit margin % 14.5 18.2
Effective tax rate % 20.4 25.3
Net profit margin % 7.7 10.3
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



RPG LIFE SCIENCES Balance Sheet Analysis

  • The company's current liabilities during FY21 down at Rs 797 million as compared to Rs 826 million in FY20, thereby witnessing an decrease of -3.5%.
  • Long-term debt down at Rs 7 million as compared to Rs 15 million during FY20, a fall of 51.3%.
  • Current assets rose 40% and stood at Rs 2 billion, while fixed assets fell 4% and stood at Rs 1 billion in FY21.
  • Overall, the total assets and liabilities for FY21 stood at Rs 3 billion as against Rs 3 billion during FY20, thereby witnessing a growth of 17%.

RPG LIFE SCIENCES Balance Sheet as on March 2021

No. of Mths Year Ending 12 Mar-20* 12 Mar-21* % Change
Networth Rs m 1,766 2,165 22.6
 
Current Liabilities Rs m 826 797 -3.5
Long-term Debt Rs m 15 7 -51.3
Total Liabilities Rs m 2,679 3,123 16.6
 
Current assets Rs m 1,258 1,759 39.8
Fixed Assets Rs m 1,421 1,365 -4.0
Total Assets Rs m 2,679 3,123 16.6
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



RPG LIFE SCIENCES Cash Flow Statement Analysis

  • RPG LIFE SCIENCES's cash flow from operating activities (CFO) during FY21 stood at Rs 583 million, an improvement of 16.1% on a YoY basis.
  • Cash flow from investing activities (CFI) during FY21 stood at Rs -80 million on a YoY basis.
  • Cash flow from financial activities (CFF) during FY21 stood at Rs -105 million, an improvement of 73% on a YoY basis.
  • Overall, net cash flows for the company during FY21 stood at Rs 398 million from the Rs 2 million net cash flows seen during FY20.

RPG LIFE SCIENCES Cash Flow Statement 2020-21

Particulars No. of months 12 12 % Change
Year Ending Mar-20 Mar-21
Cash Flow from Operating Activities Rs m 502 583 16.1%
Cash Flow from Investing Activities Rs m -107 -80 -
Cash Flow from Financing Activities Rs m -393 -105 -
Net Cash Flow Rs m 2 398 23,323.5%
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Current Valuations for RPG LIFE SCIENCES

  • The trailing twelve-month earnings per share (EPS) of the company stands at Rs 24.2, an improvement from the EPS of Rs 17.5 recorded last year.
  • The price to earnings (P/E) ratio, at the current price of Rs 387.1, stands at 16.0 times its trailing twelve months earnings.
  • The price to book value (P/BV) ratio at current price levels stands at 3.0 times, while the price to sales ratio stands at 1.6 times.
  • The company's price to cash flow (P/CF) ratio stood at 9.2 times its end-of-year operating cash flow earnings.

Per Share Data/Valuations

No. of Mths Year Ending 12 Mar-20* 12 Mar-21*
Sales per share (Unadj.) Rs 227.1 235.3
TTM Earnings per share Rs 17.5 24.2
Diluted earnings per share Rs 17.5 24.2
Price to Cash Flow x 6.2 9.2
TTM P/E ratio x 9.7 16.0
Price / Book Value ratio x 2.3 2.4
Market Cap Rs m 4,110 5,171
Dividends per share (Unadj.) Rs 4.0 7.2
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Ratio Analysis for RPG LIFE SCIENCES

  • Solvency Ratios
  • Current Ratio: The company's current ratio improved and stood at 2.2x during FY21, from 1.5x during FY20. The current ratio measures the company's ability to pay short-term and long-term obligations.

    Interest Coverage Ratio: The company's interest coverage ratio improved and stood at 30.9x during FY21, from 14.2x during FY20. The interest coverage ratio of a company states how easily a company can pay its interest expense on outstanding debt. A higher ratio is preferable.

  • Profitability Ratios
  • Return on Equity (ROE): The ROE for the company improved and stood at 18.5% during FY21, from 16.4% during FY21. The ROE measures the ability of a firm to generate profits from its shareholders capital in the company.

    Return on Capital Employed (ROCE): The ROCE for the company improved and stood at 25.5% during FY21, from 22.0% during FY20. The ROCE measures the ability of a firm to generate profits from its total capital (shareholder capital plus debt capital) employed in the company.

    Return on Assets (ROA): The ROA of the company improved and stood at 13.4% during FY21, from 11.9% during FY20. The ROA measures how efficiently the company uses its assets to generate earnings.

Key Ratio Analysis

No. of Mths Year Ending 12 Mar-20* 12 Mar-21*
Current ratio x 1.5 2.2
Debtors’ Days Days 615 539
Interest coverage x 14.2 30.9
Debt to equity ratio x 0.0 0.0
Return on assets % 11.9 13.4
Return on equity % 16.4 18.5
Return on capital employed % 22.0 25.5
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



To see how RPG LIFE SCIENCES has performed over the last 5 years, please visit here.

RPG LIFE SCIENCES Share Price Performance

Over the last one year, RPG LIFE SCIENCES share price has moved up from Rs 170.5 to Rs 387.1, registering a gain of Rs 216.7 or around 127.1%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 21,328.2 (up 0.4%). Over the last one year it has moved up from 12,148.6 to 21,328.2, a gain of 9,180 points (up 75.6%).

Overall, the S&P BSE SENSEX is up 74.1% over the year.

(To know more, check out historical annual results for RPG LIFE SCIENCES and quarterly results for RPG LIFE SCIENCES)

Annual Report FAQs

What is the current share price of RPG LIFE SCIENCES?

RPG LIFE SCIENCES currently trades at Rs 1,544.3 per share. You can check out the latest share price performance of RPG LIFE SCIENCES here...

What was the revenue of RPG LIFE SCIENCES in FY21? How does it compare to earlier years?

The revenues of RPG LIFE SCIENCES stood at Rs 3,902 m in FY21, which was up 3.6% compared to Rs 3,766 m reported in FY20.

RPG LIFE SCIENCES' revenue has grown from Rs 2,903 m in FY17 to Rs 3,902 m in FY21.

Over the past 5 years, the revenue of RPG LIFE SCIENCES has grown at a CAGR of 7.7%.

What was the net profit of RPG LIFE SCIENCES in FY21? How does it compare to earlier years?

The net profit of RPG LIFE SCIENCES stood at Rs 400 m in FY21, which was up 37.9% compared to Rs 290 m reported in FY20.

This compares to a net profit of Rs 108 m in FY19 and a net profit of Rs 135 m in FY18.

Over the past 5 years, RPG LIFE SCIENCES net profit has grown at a CAGR of 17.5%.

What does the cash flow statement of RPG LIFE SCIENCES reveal?

The cash flow statement is the financial statement that presents the cash inflows and outflows of a company during a given period of time.

This statement is one of the most useful tools for judging a company's liquidity position. The ratios and parameters in this statement helps test a company's financial health.

The cash flow statement of RPG LIFE SCIENCES reveals:

  • Cash flow from operations increased in FY21 and stood at Rs 583 m as compared to Rs 502 m in FY20.
  • Cash flow from investments increased in FY21 and stood at Rs -80 m as compared to Rs -107 m in FY20.
  • Cash flow from financial activity increased in FY21 and stood at Rs -105 m as compared to Rs -393 m in FY20.

Here's the cash flow statement of RPG LIFE SCIENCES for the past 5 years.

(Rs m)FY17FY18FY19FY20FY21
From Operations73147458502583
From Investments-301-155-190-107-80
From Financial Activity2341-265-393-105
Net Cashflow6-832398

What does the Key Ratio analysis of RPG LIFE SCIENCES reveal?

Be it the company's profitability, operations effectiveness or utilization of funds, ratio analysis is an important tool which helps in making investment decisions.

The ratio/financial analysis of RPG LIFE SCIENCES reveals:

  • Operating profit margins witnessed a fall and down at 18.2% in FY21 as against 14.5% in FY20.
  • Net profit margins grew from 7.7% in FY20 to 10.3% in FY21.
  • Debt to Equity ratio for FY21 stood at 0.0 as compared to 0.0 in FY20.

Here's the ratio/financial analysis of RPG LIFE SCIENCES for the past 5 years.

 FY17FY18FY19FY20FY21
Operating Profit Margin (%)10.210.910.414.518.2
Net Profit Margin (%)7.53.93.37.710.3
Debt to Equity Ratio (x)0.10.10.00.00.0

Read: Latest Annual Report Analysis of RPG LIFE SCIENCES

 

Equitymaster requests your view! Post a comment on "RPG LIFE SCIENCES 2020-21 Annual Report Analysis". Click here!